28 Jul 2017 | 4:51 AM
 

Cadila Healthcare Ltd. Share Price Live (BSE)
0

BSE Code: 532321 | NSE Symbol: CADILAHC
542.50
-5.15
(-0.94 %)
27 Jul 2017 | 03:45 PM
Change company
  • Open (Rs)
    549.21
  • Prev. close (Rs.)
    547.65
  • High (Rs.)
    554.00
  • Low (Rs.)
    538.46
  • 52W H (Rs.)
    558.00
  • 52W L (Rs.)
    329.95
  • Volume (Rs.)
    98200
  • MCap (Rs in Cr.)
    55,538.06

Stock Market News

Cadila Healthcare Ltd. Stock News

Company Name
From Date
To Date
  Cadila Healthcare Ltd. | 25 Jul 2017 | 14:15:00
Drug firm Zydus Cadila today said it has received final approval from US health regulator for generic Mesalamine delayed-release tablets used for treatment of ulcerative colitis...
  Cadila Healthcare Ltd. | 19 Jul 2017 | 17:36:00
Drug form Zydus Cadila today said it has received final nod from the US health regulator to market Tranexamic acid injection...
  Cadila Healthcare Ltd. | 19 Jul 2017 | 12:11:00
Leading pharma major Zydus Cadila has said that it has commercially launched its Mesalamine Delayed Release Tablets USP 1.2 mg in the US market...
  Cadila Healthcare Ltd. | 14 Jul 2017 | 17:03:00
Pharma major Zydus Cadila has said that it has received tentative approval from USFDA to market its Fingolimod Capsules 0.5 mg...
  Cadila Healthcare Ltd. | 13 Jul 2017 | 11:32:00
Drug firm Cadila Healthcare said that its chairman and MD Pankaj R Patel has stepped down as Managing Director of the company...
  Cadila Healthcare Ltd. | 12 Jul 2017 | 11:42:00
Drug maker Zydus Cadila said that it has received final approval from the United States Food & Drug Administration (USFDA) to market Memantine Hydrochloride tablets USP 5mg and 10mg...
  Cadila Healthcare Ltd. | 10 Jul 2017 | 11:03:00
Zydus Cadila has said that it has received the final approval from the USFDA to market Doxazosin Tablets USP 1 mg 2 mg 4 mg and 8 mg...
  Cadila Healthcare Ltd. | 06 Jul 2017 | 10:23:00
Leading pharma company Zydus Cadila has said that it has entered into a long-term arrangement with Phibro Animal Health Corporation to license Phibro’s innovative poultry vaccine technologies and know-how to a new vaccine manufacturing facility to be...
  Cadila Healthcare Ltd. | 05 Jul 2017 | 13:39:00
Cadila Healthcare said that it has started phase II trial of ZYAN1 for treating anemia in patients with chronic kidney disease...
  Cadila Healthcare Ltd. | 04 Jul 2017 | 11:46:00
Pharma major Cadila Healthcare Ltd on Tuesday said Zydus got tentative approval from the US health regulator to market anti-diabetic drug sitagliptin and metformin hydrochloride tablets in the US...
  Cadila Healthcare Ltd. | 30 Jun 2017 | 12:59:00
Cadila Healthcare has said that it has received the final approval from the US Food and Drug Administration (USFDA) to market Phentermine Hydrochloride Orally Disintegrating Tablets in strengths of 15 mg 30 mg and 37.5 mg...
  Cadila Healthcare Ltd. | 29 Jun 2017 | 12:37:00
Leading pharma major Cadila Healthcare has said that the subsidiary of its US arm Nesher Pharmaceuticals has received final approval from the USFDA to market Dextroamphetamine Sulfate Extended-Release Capsules 5 mg...
  Cadila Healthcare Ltd. | 28 Jun 2017 | 11:02:00
Leading pharma major Zydus Cadila has said that it has received the final approval from USFDA to market Oxybutynin Chloride Extended-Release Tablets in the strengths of 5 mg 10 mg and 15 mg...

Make smart investment decisions with Star Ratings, a stock selection tool, based upon fundamental, technical and analyst recommendations. Star Ratings provides stock trading tips for Cadila Healthcare Ltd. that will help you decide whether to buy, sell or hold Cadila Healthcare Ltd. It also provides you with switch proposals on alternative stocks, i.e., which stocks to buy against Cadila Healthcare Ltd.